The University of TX MD Anderson Cancer Center
Houston, Texas 77030
1 studies enrolling now · 3 studies all time
What they study most
Persistent or Recurrent Cutaneous T-Cell Lymphoma, Relapse/Refractory Mantle Cell Lymphoma, Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL, Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation), Relapsed/Refractory Follicular Lymphoma (FL), Relapsed/Refractory Hematological Malignancies, Relapsed/Refractory Mantle Cell Lymphoma (MCL), Relapsed/Refractory Marginal Zone Lymphoma (MZL), Relapsed/Refractory Waldenström Macroglobulinemia (WM)
Studies at this site
- A Study of APG-3288 in Relapsed/Refractory Blood Cancers — Recruiting now
- A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma — Completed
- Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies — APPROVED_FOR_MARKETING